OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
55 hedge funds and large institutions have $200M invested in OncoMed Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
Holders
55
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$11.8M | |
| 2 | +$4.33M | |
| 3 | +$4.29M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.98M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.68M |
Top Sellers
| 1 | -$3.39M | |
| 2 | -$1.76M | |
| 3 | -$1.67M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$600K |
| 5 |
EMG
Ellington Management Group
Old Greenwich,
Connecticut
|
-$440K |